<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">18523</article-id><article-id pub-id-type="doi">10.17816/KMJ2019-985</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Clinical observations</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Клинические наблюдения</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Delayed post-hypoxic leukoencephalopathy</article-title><trans-title-group xml:lang="ru"><trans-title>Отсроченная постгипоксическая лейкоэнцефалопатия</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Matveeva</surname><given-names>T V</given-names></name><name xml:lang="ru"><surname>Матвеева</surname><given-names>Татьяна Всеволодовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>valyazhu@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhukova</surname><given-names>V D</given-names></name><name xml:lang="ru"><surname>Жукова</surname><given-names>Валентина Дмитриевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>valyazhu@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Artemyeva</surname><given-names>A O</given-names></name><name xml:lang="ru"><surname>Артемьева</surname><given-names>Анастасия Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>valyazhu@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kazantsev</surname><given-names>A Yu</given-names></name><name xml:lang="ru"><surname>Казанцев</surname><given-names>Александр Юрьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>valyazhu@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">2788-1954</contrib-id><name-alternatives><name xml:lang="en"><surname>Gaifutdinov</surname><given-names>R T</given-names></name><name xml:lang="ru"><surname>Гайфутдинов</surname><given-names>Рустем Талгатович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>valyazhu@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan State Medical University</institution></aff><aff><institution xml:lang="ru">Казанский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-12-09" publication-format="electronic"><day>09</day><month>12</month><year>2019</year></pub-date><volume>100</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>985</fpage><lpage>991</lpage><history><date date-type="received" iso-8601-date="2019-12-04"><day>04</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-12-04"><day>04</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Matveeva T.V., Zhukova V.D., Artemyeva A.O., Kazantsev A.Y., Gaifutdinov R.T.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Матвеева Т.В., Жукова В.Д., Артемьева А.О., Казанцев А.Ю., Гайфутдинов Р.Т.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Matveeva T.V., Zhukova V.D., Artemyeva A.O., Kazantsev A.Y., Gaifutdinov R.T.</copyright-holder><copyright-holder xml:lang="ru">Матвеева Т.В., Жукова В.Д., Артемьева А.О., Казанцев А.Ю., Гайфутдинов Р.Т.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/18523">https://kazanmedjournal.ru/kazanmedj/article/view/18523</self-uri><abstract xml:lang="en"><p>Delayed post-hypoxic leukoencephalopathy is a clinical syndrome caused by a lesion of the white matter of the brain with an acute onset developing several days after emerging from coma. The reason of delayed post-hypoxic leukoencephalopathy is prolonged cerebral hypooxygenation, it often results from carbon monoxide poisoning, less often it is associated with acute brain hypoxia caused by respiratory failure, an overdose of opiates. The leading role in the clinical picture of delayed post-hypoxic leukoencephalopathy is played by the duration and severity of cerebral anoxia in the acute period of the disease. The period of temporary well-being of a patient with an episode of acute hypoxia lasts 2 to 40 days. Pathogenesis and pathophysiology have not been well studied. Its development after carbon monoxide poisoning is considered to be caused by direct myelinotoxic effect. It is essential to collect a detailed history for diagnosing a case, neurovisualization is an informative method for investigation. Magnetic resonance imaging may detect the signs that are pathognomonic for delayed post-hypoxic leukoencephalopathy, that is diffuse hyperintensity of the white matter of the cerebral hemispheres in T2-mode, symmetry of the damage of both cerebral hemispheres, damage of the subcortical gray matter — globus pallidus. The standards for the treatment of delayed post-hypoxic leukoencephalopathy have not been developed. The use of glucocorticoids has been described, perspective use of amantadine were shown in case of frontal-subcortical syndrome. There are recommendations on prescribing the following therapy for the patients with delayed post-hypoxic leukoencephalopathy: hyperbaric oxygenation, coenzyme Q10, vitamin E and group B. We present a clinical observation that demonstrates the complexity of the clinical picture of delayed post-hypoxic leukoencephalopathy, the difficulty of its diagnosis without taking into account information about previous carbon monoxide poisoning. The results of magnetic resonance imaging at the onset of the disease are considered to be of utmost interest. The clinical observation of the patient presented in the article allows us to make an assumption about pathogenesis and contributes to search for means aimed at preventing the development of delayed post-hypoxic leukoencephalopathy in people with acute carbon monoxide poisoning.</p></abstract><trans-abstract xml:lang="ru"><p>Отсроченная постгипоксическая лейкоэнцефалопатия — клинический синдром, обусловленный поражением белого вещества головного мозга, возникающий через несколько дней после выхода из комы, имеющий острое начало. Причина отсроченной постгипоксической лейкоэнцефалопатии — продолжительная церебральная гипооксигенация, часто она бывает следствием отравления угарным газом, реже ассоциирована с острой гипоксией головного мозга, вызванной дыхательной недостаточностью, передозировкой опиатов. Ведущую роль в клинической картине отсроченной постгипоксической лейкоэнцефалопатии играют продолжительность и выраженность церебральной аноксии в острый период заболевания. Период временного благополучия у пациента, пережившего эпизод острой гипоксии, длится от 2 до 40 дней. Патогенез и патофизиология изучены недостаточно. Считают, что её развитие после отравления угарным газом обусловлено прямым миелинотоксическим действием. При постановке диагноза большое значение имеет сбор подробного анамнеза, информативным инструментальным методом исследования служит нейровизуализация. С помощью магнитно-резонансной томографии можно обнаружить патогномоничные для отсроченной постгипоксической лейкоэнцефалопатии признаки — диффузную гиперинтенсивность белого вещества больших полушарий в Т2-режиме, симметричность поражения обоих полушарий головного мозга, поражение подкоркового серого вещества — globus pallidus. Стандартов лечения отсроченной постгипоксической лейкоэнцефалопатии не разработано. Описано применение глюкокортикоидов, показана перспективность амантадина при наличии лобно-подкоркового синдрома. Существуют рекомендации о назначении больным отсроченной постгипоксической лейкоэнцефалопатией поддерживающей терапии: гипербарическая оксигенация, коэнзим Q10, витамины Е и группы В. Мы представили клиническое наблюдение, которое демонстрирует сложность клинической картины отсроченной постгипоксической лейкоэнцефалопатии, трудность её диагностики без учёта сведений о предшествующем отравлении угарным газом. Безусловный интерес представляют результаты магнитно-резонансной томографии в дебюте заболевания. Представленное в статье клиническое наблюдение за нашим пациентом позволяет сделать предположение о патогенезе и делает перспективным поиск средств, направленных на профилактику развития отсроченной постгипоксической лейкоэнцефалопатии у людей, перенёсших острое отравление угарным газом.</p></trans-abstract><kwd-group xml:lang="en"><kwd>carbon monoxide poisoning</kwd><kwd>delayed post-hypoxic leukoencephalopathy</kwd><kwd>cerebral anoxia</kwd><kwd>case report</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>отравление угарным газом</kwd><kwd>отсроченная постгипоксическая лейкоэнцефалопатия</kwd><kwd>церебральная аноксия</kwd><kwd>клиническое наблюдение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Shprecher D., Mehta L. The syndrome of delayed post-hypoxic leukoencephalopathy. NeuroRehabilitation. 2010; 26 (1): 65–72. PMID: 20166270.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Zamora C.A., Nauen D., Hynecek R. Delayed posthypoxic leukoencephalopathy: a case series and review of the literature. Brain Behav. 2015; 5 (8): e00364. DOI: 10.1002/brb3.364.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Centers for Disease Control and Prevention (CDC). MMWR Morb. Mortal. Weekly Rep. 2005; 54 (2): 36–39.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Beeskow A.B., Oberstadt M., Saur D. Delayed Post-hypoxic Leukoencephalopathy (DPHL) — An uncommon variant of hypoxic brain damage in adults. Front. Neurol. 2018; 9: 708. DOI: 10.3389/fneur.2018.00708.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Rizzuto N., Morbin M., Ferrari S. Delayed spongiform leukoencephalopathy after heroin abuse. Acta. Neuropathol. 1997; 94 (1): 87–90. DOI: 10.1007/s004010050676.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sener R.N. Metachromatic leukodystrophy: diffusion MR imaging findings. AJNR Am. J. Neuroradiol. 2002; 23 (8): 1424–1426. PMID: 12223391.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Gieselmann V., Krägeloh-Mann I. Metachromatic leukodystrophy — an update. Neuropediatrics. 2010; 41 (1): 1–6. DOI: 10.1055/s-0030-1253412.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Polten A., Fluharty A.L., Fluharty C.B. Molecular basis of different forms of metachromatic leukodystrophy. N. Engl. J. Med. 1991; 324: 18–22. DOI: 10.1056/NEJM199101033240104.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ginsburg R., Romano J. Carbon monoxide encephalo­pathy: need for appropriate treatment. Am. J. Psychiatry. 1976; 133 (3): 317–320. DOI: 10.1176/ajp.133.3.317.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Benarroch E.E. Oligodendrocytes. Susceptibility to injury and involvement in neurologic disease. Clin. Implic. Neurosci. Res. 2009; 72 (20): 1779–1785. DOI: 10.1212/WNL.0b013e3181a6b123.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Miró Ò., Casademont J., Barrientos A. et al. Mitochondrial cytochrome c oxidase inhibition during acute carbon mono­xide poisoning. Pharmacol. Toxicol. 1998; 82 (4): 199–202. DOI: 10.1111/j.1600-0773.1998.tb01425.x.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Thom S.R., Bhopale V.M., Fisher D. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc. Natl. Acad. Sci. USA. 2004; 101 (37): 13 660–13 665. DOI: 10.1073/pnas.0405642101.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lee M.S., Marsden C.D. Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings. Mov. Disord. 1994; (5): 550–558. DOI: 10.1002/mds.870090508.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Geraldo A.F., Silva C., Neto L.L. et al. Delayed leukoencephalopathy after acute carbon monoxide intoxication. J. Radiol. Case Rep. 2014; 8 (5): 1–8. DOI: 10.3941/jrcr.v8i5.1721.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Choi I.S. Carbon monoxide poisoning: Systemic manifestations and complications. J. Korean Med. Sci. 2001; 16: 253–261. DOI: 10.3346/jkms.2001.16.3.253.</mixed-citation></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Ostapenko Yu.N., Zobnin Yu.V., Lezhenina N.F. Toksicheskoe deystvie okisi ugleroda. Federal`nye klinicheskie recommendatsii. (Toxic effect of carbon monoxide. Federal clinical guidelines.) Мoscow. 2013; 38 р. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Остапенко Ю.Н., Зобнин Ю.В., Леженина Н.Ф. Токсическое действие окиси углерода. Федеральные клинические рекомендации. М. 2013; 38 с.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><mixed-citation>Shprecher D.R., Flanigan K.M., Smith A.G. Clinical and diagnostic features of delayed hypoxic leukoencephalopathy. J. Neuropsychiatry Clin. Neurosci. 2008; 20 (4): 473–477. DOI: 10.1176/appi.neuropsych.20.4.473.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Sener R.N. Acute carbon monoxide poisoning: Diffusion MR imaging findings. Am. J. Neuroradiol. 2003; 24 (7): 1475–1477. PMID: 12917151.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kim D.M., Lee I.H., Park J.Y. Acute carbon mono­xide poisoning: MR imaging findings with clinical correlation. Diagn. Interv. Imaging. 2017; 98 (4): 299–306. DOI: 10.1016/j.diii.2016.10.004.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kim J.H., Chang K.H., Song I.C. Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. AJNR Am. J. Neuroradiol. 2003; 24 (8): 1592–1597. PMID: 13679276.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Beppu T. The role of MR imaging in assessment of brain damage from carbon monoxide poisoning: A review of the lite­rature. Am. J. Neuroradiol. 2014; 35 (4): 1–7. DOI: 10.3174/ajnr.A3489.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Finelli P.F., DiMario J. MR imaging and prognosis of hypoxic-ischemic leukoencephalopathy. Neurocrit. Care. 2006; 4 (2): 119–126. DOI: 10.1385/NCC:4:2:119.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Manoj M., Wang Y., Reeves A. Methadone-induced delayed posthypoxic encephalopathy: Clinical, radiological, and pathological findings. Case Rep. Med. 2010; 716494: 1–4. DOI: 10.1155/2010/716494.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Arciniegas D.B., Frey K.L., Anderson C.A. Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Inj. 2004; 18 (12): 1309–1318. DOI: 10.1080/02699050410001720130.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Price J.D., Grimley E.J. An N-of-1 randomized controlled trial ('N-of-1 trial’) of donepezil in the treatment of non-progressive amnestic syndrome. Age Ageing. 2002; 31 (4): 307–309. DOI: 10.1093/ageing/31.4.307.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Rozen T.D. Rapid resolution of akinetic mutism in delayed post-hypoxic leukoencephalopathy with intravenous magnesium sulfate. NeuroRehabilitation. 2012; 30 (4): 329–332. DOI: 10.3233/NRE-2012-0763.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Scheinkestel C.D., Bailey M., Myles P.S. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med. J. Aust. 1999; 170 (5): 203–210. DOI: 10.5694/j.1326-5377.1999.tb140318.x.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Carroll I., Heritier Barras A.-C., Dirren E. Delayed leukoencephalopathy after alprazolam and methadone overdose: A case report and review of the literature. Clin. Neurol. Neurosurg. 2012; 114 (6): 816–819. DOI: 10.1016/j.clineuro.2011.12.052.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>King F., Morris N.A., Schmahmann J.D. Delayed Posthypoxic leukoencephalopathy: Improvement with antioxidant therapy. Case Rep. Neurol. 2015; 7 (3): 242–246. DOI: 10.1159/000441892.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Cocito L., Biagioli M., Fontana P. Cognitive reco­very after delayed carbon monoxide encephalopathy. Clin. Neurol. Neurosurg. 2005; 107 (4): 347–350. DOI: 10.1016/j.clineuro.2004.09.008.</mixed-citation></ref></ref-list></back></article>
